中商官网
研究报告
大博医疗（002901）
主要经济指标
| 类别\年份 | 营业收入 （元) |
营业利润 （元) |
利润总额 （元) |
净利润 （元) |
资产总计 （元) |
负债合计 （元) |
股东权益合计 （元) |
| 2013 | 203000000.0000 | 109000000.0000 | 115000000.0000 | 96603300.0000 | 296000000.0000 | 71578300.0000 | 225000000.0000 |
| 2014 | 299000000.0000 | 160000000.0000 | 166000000.0000 | 138000000.0000 | 545000000.0000 | 271000000.0000 | 274000000.0000 |
| 2015 | 392000000.0000 | 214000000.0000 | 224000000.0000 | 189000000.0000 | 561000000.0000 | 120000000.0000 | 442000000.0000 |
| 2016 | 463000000.0000 | 243000000.0000 | 262000000.0000 | 222000000.0000 | 719000000.0000 | 139000000.0000 | 580000000.0000 |
| 2017 | 594000000.0000 | 351000000.0000 | 350000000.0000 | 301000000.0000 | 1388000000.0000 | 150000000.0000 | 1239000000.0000 |
| 2018 | 772000000.0000 | 441000000.0000 | 441000000.0000 | 378000000.0000 | 1665000000.0000 | 207000000.0000 | 1458000000.0000 |
| 2019 | 1257000000.0000 | 571000000.0000 | 569000000.0000 | 479000000.0000 | 2239000000.0000 | 485000000.0000 | 1753000000.0000 |
| 2020 | 1587000000.0000 | 715000000.0000 | 710000000.0000 | 615000000.0000 | 2638000000.0000 | 504000000.0000 | 2134000000.0000 |
| 2021 | 1994000000.0000 | 822000000.0000 | 803000000.0000 | 692000000.0000 | 3380000000.0000 | 791000000.0000 | 2588000000.0000 |
| 2022 | 1434000000.0000 | 147000000.0000 | 147000000.0000 | 110000000.0000 | 3938000000.0000 | 831000000.0000 | 3106000000.0000 |
| 2023 | 1533000000.0000 | 103000000.0000 | 99740800.0000 | 86336000.0000 | 4640000000.0000 | 1479000000.0000 | 3161000000.0000 |
| 2024 | 2136000000.0000 | 430000000.0000 | 428000000.0000 | 385000000.0000 | 4419000000.0000 | 1237000000.0000 | 3182000000.0000 |
盈利能力分析
| 类别\年份 | 销售毛利率 （%) |
营业利润率 （%) |
总资产利润率 （%) |
净资产收益率 | 存货周转率 | 应收账款周转率 （次) |
总资产周转率 （次) |
| 2013 | 53.23 | 56.65 | 38.85 | 56.6300 | 0.7100 | 7.40 | 0.69 |
| 2014 | 52.84 | 55.52 | 30.46 | 47.8000 | 0.8100 | 9.39 | 0.55 |
| 2015 | 54.08 | 57.14 | 39.93 | 54.4200 | 0.7100 | 7.87 | 0.70 |
| 2016 | 52.05 | 56.59 | 36.44 | 41.8700 | 0.6000 | 7.75 | 0.64 |
| 2017 | 52.53 | 58.92 | 25.22 | 37.7600 | 0.5600 | 10.12 | 0.43 |
| 2018 | 49.87 | 57.12 | 26.49 | 28.1000 | 0.6500 | 10.99 | 0.46 |
| 2019 | 41.21 | 45.27 | 25.41 | 29.7600 | 0.5000 | 7.94 | 0.56 |
| 2020 | 40.77 | 44.74 | 26.91 | 32.0100 | 0.4500 | 6.01 | 0.60 |
| 2021 | 36.31 | 40.27 | 23.76 | 29.6400 | 0.5100 | 5.43 | 0.59 |
| 2022 | 3.77 | 10.25 | 3.73 | 3.2000 | 0.4000 | 3.73 | 0.36 |
| 2023 | 1.63 | 6.51 | 2.15 | 1.9500 | 0.4500 | 5.41 | 0.33 |
| 2024 | 15.31 | 20.04 | 9.69 | 11.3300 | 0.5400 | 8.94 | 0.48 |
偿债能力分析
| 类别\年份 | 资产负债率 （%) |
股东权益比率 （%) |
流动比率 | 速动比率 |
| 2013 | 24.18 | 76.01 | 2.8800 | 1.1400 |
| 2014 | 49.72 | 50.28 | 1.3000 | 0.8600 |
| 2015 | 21.39 | 78.79 | 3.5200 | 1.2400 |
| 2016 | 19.33 | 80.67 | 4.2200 | 1.1300 |
| 2017 | 10.81 | 89.27 | 9.4100 | 4.9500 |
| 2018 | 12.43 | 87.57 | 7.5400 | 5.1900 |
| 2019 | 21.66 | 78.29 | 3.8700 | 2.7400 |
| 2020 | 19.11 | 80.89 | 4.4700 | 3.1200 |
| 2021 | 23.40 | 76.57 | 3.3200 | 2.2800 |
| 2022 | 21.10 | 78.87 | 3.8000 | 2.3500 |
| 2023 | 31.88 | 68.13 | 2.7400 | 1.6600 |
| 2024 | 27.99 | 72.01 | 2.9900 | 1.5900 |
成本费用分析
| 类别\年份 | 营业成本 （元) |
销售费用 （元) |
管理费用 （元) |
财务费用 （元) |
| 2013 | 94949700.0000 | 20340900.0000 | 29107500.0000 | 463600.0000 |
| 2014 | 141000000.0000 | 28156800.0000 | 43030100.0000 | 538700.0000 |
| 2015 | 180000000.0000 | 41738600.0000 | 62636800.0000 | -111600.0000 |
| 2016 | 222000000.0000 | 52966200.0000 | 76988700.0000 | -3393700.0000 |
| 2017 | 282000000.0000 | 72201500.0000 | 34275300.0000 | 3697100.0000 |
| 2018 | 387000000.0000 | 121000000.0000 | 42474700.0000 | -14019700.0000 |
| 2019 | 739000000.0000 | 410000000.0000 | 45190500.0000 | -27971600.0000 |
| 2020 | 940000000.0000 | 502000000.0000 | 62803800.0000 | -13522900.0000 |
| 2021 | 1270000000.0000 | 655000000.0000 | 91762900.0000 | -7815900.0000 |
| 2022 | 1380000000.0000 | 663000000.0000 | 125000000.0000 | -23176900.0000 |
| 2023 | 1508000000.0000 | 565000000.0000 | 126000000.0000 | -19387400.0000 |
| 2024 | 1809000000.0000 | 630000000.0000 | 139000000.0000 | -6342300.0000 |